Events

IRIDS Virtual Science Talks

Welcome to the IRIDS Virtual Science Talks
The spirit of IRIDS
 

IRIDS (International Roche Infectious Diseases Symposium) comprises a series of scientific and educational events taking place since 2009, addressing some of the most significant, up-to-date topics in the field of infectious disease (ID) management and diagnosis. IRIDS is the perfect forum for laboratory experts and clinical specialists from around the world, to exchange insights and expertise in the infectious diseases field.  

 

The IRIDS Virtual Science Talks
 

In 2022, Roche has initiated a series of webinars with the aim of engaging, informing, and inspiring healthcare professionals worldwide.
Scientists and industry leaders will share their thoughts and experiences within the field of infectious diseases, on a platform built to facilitate and enhance conversations and sometimes also debates.

 

Three reasons to attend
 

Stay up to date on the global trends and most significant development on infectious diseases.

Discover more about trends and current innovations around respiratory diseases, viral hepatitis, sexual transmitted diseases, and congenital infection, just to mention a few.

Connect with lab experts, clinicians, industry leaders from other countries.

Attendance to the IRIDS Virtual is free of charge. No CME points will be provided, but it will be possible to get a Certificate of Attendance.

 

Sign up now to unlock the IRIDS virtual platform and it's exclusive content

 

Register now for the upcoming IRIDS Virtual Science Talks: 'Understanding Hepatitis B: Markers, Outcomes, and Stigma' planned for July 24th 2025 at 13:00 - 14:00 pm CET

with

Prof. Thomas Vanwolleghem
Professor of Hepatology at the University of Antwerp, Faculty of Medicine and Health Sciences, Belgium
 

Dr. Sabela Lens García
Hepatologist in the Liver Unit at the Hospital Clínic of Barcelona, Spain
 

Rachel Halford
President, The World Hepatitis Alliance, UK

 

References:

  1. Background and summary of the current situation by CDC. Available at: https://www.cdc.gov/bird-flu/situation-summary/inhumans.html [Accessed 03 Apr 2025]

  2. CDC A(H5N1) Bird Flu Response Update March 19, 2025. Available at: https://www.cdc.gov/bird-flu/spotlights/h5n1-response-03192025.html  [Accessed 03 Apr 2025]
  3. World Health Organization fact sheet on dengue. Available at: https://www.who.int/ news-room/fact-sheets/detail/dengue-and-severe-dengue  [Accessed 30 Aug 2024].
  4. ECDC perspective on dengue for Europe. Available at: https://www.ecdc.europa.eu /en/all-topics-z/dengue/surveillance-and-disease-data/autochthonous-transmission-dengue-virus-eueea [Accessed 30 Aug 2024].
  5. Brady, O.J., et al., Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLOS Neglected Tropical Diseases, 2012. 6(8): p. e1760.
  6. Balayan MS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983; 20:23–31. 
  7. World Health Organization. Hepatitis E factsheet. [Internet; updated 2023 July; cited 2024 August].
    Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-e
  8. Elecsys Anti-HEV IgM Method sheet (Mat. N. 09056246190 & 09056254190; V1 2023-03.
  9. Elecsys Anti-HEV IgG Method sheet (Mat. N. 09044639190 & 09044647190; V1 2023-09.